SUPPLIERS
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Click Us!
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23874
Submission : 2010-06-09
Status :
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17451
Submission : 2004-05-27
Status :
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17452
Submission : 2004-05-27
Status :
Type : IV
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]LISTED SUPPLIERS
FINISHED DOSAGE FORMULATIONS
FDF DOSSIERS SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Expansorb® PLGA / PEG
Application : Parenteral
Excipient Details : Expansorb® PLGA / PEG copolymers are used as functional excipients in single dose injections for controlled and slow drug release (weeks to months).
Pharmacopoeia Ref : N/A
Technical Specs : Classic and ultrapure LMP
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Polylactide-co-glycolide (75:25)
Application : Parenteral
Excipient Details : Poly (lactide-co-glycolide) (75:25) is used as a carrier material for sustained-release formulations including microspheres, nanocapsules & gels.
Pharmacopoeia Ref : ChP/USP
Technical Specs : Polylactide-co-glycolide (75:25); Intrinsic Viscosity: 20-30 mL/g...
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Application : Parenteral
Excipient Details : Expansorb® PLGA copolymers are used as functional excipients for slow and controlled drug release (weeks to months) with a single injection.
Pharmacopoeia Ref : NA
Technical Specs : Classic and ultrapure LMP
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Polylactide-co-glycolide (50:50)
Application : Parenteral
Excipient Details : Poly(lactide-co-glycolide) (50:50) is a biodegradable carrier used in parenteral dosage forms. It is also used to develop controlled release products.
Pharmacopoeia Ref : ChP/USP
Technical Specs : Polylactide-co-glycolide (50:50); Intrinsic Viscosity: 15-25 mL/g...
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Expansorb® PLGA 55:45-Glu
Application : Parenteral
Excipient Details : Expansorb® PLGA 55:45-Glu is lactic acid & glycolic acid copolymer used as functional excipients in injectables for slow and controlled drug release.
Pharmacopoeia Ref : NA
Technical Specs : Classic and ultrapure LMP
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Polylactide-co-glycolide (85:15)
Application : Parenteral
Excipient Details : Poly (lactide-co-glycolide) (85:15) is a biodegradable carrier used in parenteral controlled release dosage forms such as microspheres & nanocapsules.
Pharmacopoeia Ref : ChP/USP
Technical Specs : Polylactide-co-glycolide (85:15); Intrinsic Viscosity: 15-25 mL/g...
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Controlled Modified Release
Digital Content
DATA COMPILATION #PharmaFlow
MARKET PLACE
EXCIPIENTS
Reply
09 Dec 2024
Reply
23 Oct 2024
Reply
25 Jan 2022
Reply
16 Sep 2021
Reply
23 Oct 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Comment (7)
